Literature DB >> 28807910

24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.

J Nicholas O'Donnell1, Nathaniel J Rhodes1, Thomas P Lodise2, Walter C Prozialeck3, Cristina M Miglis1, Medha D Joshi4, Natarajan Venkatesan4, Gwendolyn Pais4, Cameron Cluff1, Peter C Lamar3, Seema Briyal4, John Z Day1, Anil Gulati4, Marc H Scheetz5.   

Abstract

Vancomycin has been associated with acute kidney injury in preclinical and clinical settings; however, the precise exposure profiles associated with vancomycin-induced acute kidney injury have not been defined. We sought to determine pharmacokinetic/pharmacodynamics indices associated with the development of acute kidney injury using sensitive urinary biomarkers. Male Sprague-Dawley rats received clinical-grade vancomycin or normal saline as an intraperitoneal injection. Total daily doses between 0 and 400 mg/kg of body weight were administered as a single dose or 2 divided doses over a 24-h period. At least five rats were utilized for each dosing protocol. A maximum of 8 plasma samples per rat were obtained, and urine was collected over the 24-h period. Kidney injury molecule-1 (KIM-1), clusterin, osteopontin, cystatin C, and neutrophil gelatinase-associated lipocalin levels were determined using Milliplex multianalyte profiling rat kidney panels. Vancomycin plasma concentrations were determined via a validated high-performance liquid chromatography methodology. Pharmacokinetic analyses were conducted using the Pmetrics package for R. Bayesian maximal a posteriori concentrations were generated and utilized to calculate the 24-h area under the concentration-time curve (AUC), the maximum concentration (Cmax), and the minimum concentration. Spearman's rank correlation coefficient (rs ) was used to assess the correlations between exposure parameters, biomarkers, and histopathological damage. Forty-seven rats contributed pharmacokinetic and toxicodynamic data. KIM-1 was the only urinary biomarker that correlated with both composite histopathological damage (rs = 0.348, P = 0.017) and proximal tubule damage (rs = 0.342, P = 0.019). The vancomycin AUC and Cmax were most predictive of increases in KIM-1 levels (rs = 0.438 and P = 0.002 for AUC and rs = 0.451 and P = 0.002 for Cmax). Novel urinary biomarkers demonstrate that kidney injury can occur within 24 h of vancomycin exposure as a function of either AUC or Cmax.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  acute kidney injury; biological markers; pharmacodynamics; pharmacokinetics; vancomycin

Mesh:

Substances:

Year:  2017        PMID: 28807910      PMCID: PMC5655072          DOI: 10.1128/AAC.00416-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.

Authors:  Faruk Oktem; Meltem Koyuncu Arslan; Fehmi Ozguner; Ozden Candir; H Ramazan Yilmaz; Metin Ciris; Efkan Uz
Journal:  Toxicology       Date:  2005-08-19       Impact factor: 4.221

2.  Acute kidney injury in the intensive care unit according to RIFLE.

Authors:  Marlies Ostermann; René W S Chang
Journal:  Crit Care Med       Date:  2007-08       Impact factor: 7.598

3.  Impact of vancomycin treatment duration and dose on kidney injury.

Authors:  Kirsten Bosch; Milena M McLaughlin; John S Esterly; Nathaniel J Rhodes; Michael J Postelnick; Marc H Scheetz
Journal:  Int J Antimicrob Agents       Date:  2013-12-07       Impact factor: 5.283

4.  Are vancomycin trough concentrations adequate for optimal dosing?

Authors:  Michael N Neely; Gilmer Youn; Brenda Jones; Roger W Jelliffe; George L Drusano; Keith A Rodvold; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

5.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; Willam A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

6.  Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

Authors:  Richard G Wunderink; Michael S Niederman; Marin H Kollef; Andrew F Shorr; Mark J Kunkel; Alice Baruch; William T McGee; Arlene Reisman; Jean Chastre
Journal:  Clin Infect Dis       Date:  2012-01-12       Impact factor: 9.079

7.  Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury.

Authors:  Vishal S Vaidya; Victoria Ramirez; Takaharu Ichimura; Norma A Bobadilla; Joseph V Bonventre
Journal:  Am J Physiol Renal Physiol       Date:  2005-09-20

8.  Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.

Authors:  Vishal S Vaidya; Josef S Ozer; Frank Dieterle; Fitz B Collings; Victoria Ramirez; Sean Troth; Nagaraja Muniappa; Douglas Thudium; David Gerhold; Daniel J Holder; Norma A Bobadilla; Estelle Marrer; Elias Perentes; André Cordier; Jacky Vonderscher; Gérard Maurer; Peter L Goering; Frank D Sistare; Joseph V Bonventre
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

9.  Preclinical evaluation of novel urinary biomarkers of cadmium nephrotoxicity.

Authors:  Walter C Prozialeck; Joshua R Edwards; Vishal S Vaidya; Joseph V Bonventre
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-06       Impact factor: 4.219

10.  Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study.

Authors:  Theodoros Kelesidis; Nikolay Braykov; Daniel Z Uslan; Daniel J Morgan; Sumanth Gandra; Birgir Johannsson; Marin L Schweizer; Scott A Weisenberg; Heather Young; Joseph Cantey; Eli Perencevich; Edward Septimus; Arjun Srinivasan; Ramanan Laxminarayan
Journal:  Infect Control Hosp Epidemiol       Date:  2015-10-12       Impact factor: 3.254

View more
  17 in total

1.  Rutin Attenuates Vancomycin-Induced Nephrotoxicity by Ameliorating Oxidative Stress, Apoptosis, and Inflammation in Rats.

Authors:  Shaoqi Qu; Cunchun Dai; Fengting Lang; Longfei Hu; Qihe Tang; Haixia Wang; Yanping Zhang; Zhihui Hao
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 2.  Mechanisms of antimicrobial-induced nephrotoxicity in children.

Authors:  Kevin J Downes; Molly Hayes; Julie C Fitzgerald; Gwendolyn M Pais; Jiajun Liu; Nicole R Zane; Stuart L Goldstein; Marc H Scheetz; Athena F Zuppa
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

3.  Evaluation of Dose-Fractionated Polymyxin B on Acute Kidney Injury Using a Translational In Vivo Rat Model.

Authors:  Jiajun Liu; Gwendolyn M Pais; Sean N Avedissian; Annette Gilchrist; Andrew Lee; Nathaniel J Rhodes; Alan R Hauser; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

4.  Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis.

Authors:  Doaa M Aljefri; Sean N Avedissian; Nathaniel J Rhodes; Michael J Postelnick; Kevin Nguyen; Marc H Scheetz
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

5.  The Pharmacodynamic-Toxicodynamic Relationship of AUC and C max in Vancomycin-Induced Kidney Injury in an Animal Model.

Authors:  Sean N Avedissian; Gwendolyn Pais; Jiajun Liu; J Nicholas O'Donnell; Thomas P Lodise; Michael Neely; Walter C Prozialeck; Peter C Lamar; Leighton Becher; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

6.  Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.

Authors:  Gwendolyn M Pais; Sean N Avedissian; J Nicholas O'Donnell; Nathaniel J Rhodes; Thomas P Lodise; Walter C Prozialeck; Peter C Lamar; Cameron Cluff; Anil Gulati; Julie C Fitzgerald; Kevin J Downes; Athena F Zuppa; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

7.  Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model.

Authors:  Medha D Joshi; Gwendolyn M Pais; Jack Chang; Khrystyna Hlukhenka; Sean N Avedissian; Anil Gulati; Walter C Prozialeck; Peter C Lamar; Zhong Zhang; Marc H Scheetz; Brooke Griffin
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

8.  Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.

Authors:  Sean N Avedissian; Gwendolyn M Pais; J Nicholas O'Donnell; Thomas P Lodise; Jiajun Liu; Walter C Prozialeck; Medha D Joshi; Peter C Lamar; Leighton Becher; Anil Gulati; William Hope; Marc H Scheetz
Journal:  J Antimicrob Chemother       Date:  2019-08-01       Impact factor: 5.790

9.  Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.

Authors:  Ahmed A Mahmoud; Sean N Avedissian; Abbas Al-Qamari; Tiffany Bohling; Michelle Pham; Marc H Scheetz
Journal:  Clin Pharmacokinet       Date:  2020-12       Impact factor: 6.447

Review 10.  Vancomycin-Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.

Authors:  Gwendolyn M Pais; Jiajun Liu; Sanja Zepcan; Sean N Avedissian; Nathaniel J Rhodes; Kevin J Downes; Ganesh S Moorthy; Marc H Scheetz
Journal:  Pharmacotherapy       Date:  2020-05-04       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.